Amanote Research
Register
Sign In
Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP4 Inhibitors for the Treatment of Type 2 Diabetes
doi 10.1021/acsmedchemlett.6b00027.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
Furan-2-Ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase G
The Docking of Protein DPP4 and Drug Molecules for Type 2 Diabetes
Advances in Clinical Medicine
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(Adamant-2-Yl) Acetamide 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
Selective PDE4 Inhibitors as Potent Anti-Inflammatory Drugs for the Treatment of Airway Diseases
Memorias do Instituto Oswaldo Cruz
Medicine
Microbiology
Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Discovery of Substituted 4-(Pyrazol-4-Yl)-Phenylbenzodioxane-2-Carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
